Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 108

1.
2.

Recombinant M2e protein-based ELISA: a novel and inexpensive approach for differentiating avian influenza infected chickens from vaccinated ones.

Hemmatzadeh F, Sumarningsih S, Tarigan S, Indriani R, Dharmayanti NL, Ebrahimie E, Igniatovic J.

PLoS One. 2013;8(2):e56801. doi: 10.1371/journal.pone.0056801. Epub 2013 Feb 21.

3.
4.

Vaccination with different M2e epitope densities confers partial protection against H5N1 influenza A virus challenge in chickens.

Zhang X, Liu M, Liu C, Du J, Shi W, Sun E, Li H, Li J, Zhang Y.

Intervirology. 2011;54(5):290-9. doi: 10.1159/000319440. Epub 2011 Jan 13.

PMID:
21228535
5.

Immunogenicity and protective efficacy of the norovirus P particle-M2e chimeric vaccine in chickens.

Elaish M, Kang KI, Xia M, Ali A, Shany SA, Wang L, Jiang X, Lee CW.

Vaccine. 2015 Sep 11;33(38):4901-9. doi: 10.1016/j.vaccine.2015.07.049. Epub 2015 Jul 29.

PMID:
26232342
6.

Complete protection against a H5N2 avian influenza virus by a DNA vaccine expressing a fusion protein of H1N1 HA and M2e.

Park KS, Seo YB, Lee JY, Im SJ, Seo SH, Song MS, Choi YK, Sung YC.

Vaccine. 2011 Jul 26;29(33):5481-7. doi: 10.1016/j.vaccine.2011.05.062. Epub 2011 Jun 12.

PMID:
21664216
7.

Prokaryote-expressed M2e protein improves H9N2 influenza vaccine efficacy and protection against lethal influenza A virus in mice.

Kim EH, Lee JH, Pascua PN, Song MS, Baek YH, Kwon HI, Park SJ, Lim GJ, Decano A, Chowdhury MY, Seo SK, Song MK, Kim CJ, Choi YK.

Virol J. 2013 Apr 3;10:104. doi: 10.1186/1743-422X-10-104.

8.

Field application of the H9M2e enzyme-linked immunosorbent assay for differentiation of H9N2 avian influenza virus-infected chickens from vaccinated chickens.

Kim MC, Choi JG, Kwon JS, Kang HM, Paek MR, Jeong OM, Kwon JH, Lee YJ.

Clin Vaccine Immunol. 2010 Dec;17(12):1977-84. doi: 10.1128/CVI.00191-10. Epub 2010 Oct 27.

9.
11.

An M2e-based synthetic peptide vaccine for influenza A virus confers heterosubtypic protection from lethal virus challenge.

Ma JH, Yang FR, Yu H, Zhou YJ, Li GX, Huang M, Wen F, Tong G.

Virol J. 2013 Jul 9;10:227. doi: 10.1186/1743-422X-10-227.

12.

Vaccination of chickens with recombinant Salmonella expressing M2e and CD154 epitopes increases protection and decreases viral shedding after low pathogenic avian influenza challenge.

Layton SL, Kapczynski DR, Higgins S, Higgins J, Wolfenden AD, Liljebjelke KA, Bottje WG, Swayne D, Berghman LR, Kwon YM, Hargis BM, Cole K.

Poult Sci. 2009 Nov;88(11):2244-52. doi: 10.3382/ps.2009-00251. Review.

PMID:
19834072
13.

[Construction and immunogenicity of recombinant bacteriophage T7 vaccine expressing M2e peptides of avian influenza virus].

Xu H, Wang YW, Tang YH, Zheng QS, Hou JB.

Bing Du Xue Bao. 2013 Jun;29(4):376-81. Chinese.

PMID:
23895000
14.

Enhanced immune response induced by a potential influenza A vaccine based on branched M2e polypeptides linked to tuftsin.

Liu X, Guo J, Han S, Yao L, Chen A, Yang Q, Bo H, Xu P, Yin J, Zhang Z.

Vaccine. 2012 Oct 12;30(46):6527-33. doi: 10.1016/j.vaccine.2012.08.054. Epub 2012 Sep 7.

PMID:
22959982
15.

Immunization with M2e-displaying T7 bacteriophage nanoparticles protects against influenza A virus challenge.

Hashemi H, Pouyanfard S, Bandehpour M, Noroozbabaei Z, Kazemi B, Saelens X, Mokhtari-Azad T.

PLoS One. 2012;7(9):e45765. doi: 10.1371/journal.pone.0045765. Epub 2012 Sep 24.

16.

Heterosubtypic protection conferred by combined vaccination with M2e peptide and split influenza vaccine.

Wu F, Yuan XY, Huang WS, Chen YH.

Vaccine. 2009 Oct 9;27(43):6095-101. doi: 10.1016/j.vaccine.2008.11.037. Epub 2008 Dec 3.

PMID:
19056447
17.

Potent immunogenicity and efficacy of a universal influenza vaccine candidate comprising a recombinant fusion protein linking influenza M2e to the TLR5 ligand flagellin.

Huleatt JW, Nakaar V, Desai P, Huang Y, Hewitt D, Jacobs A, Tang J, McDonald W, Song L, Evans RK, Umlauf S, Tussey L, Powell TJ.

Vaccine. 2008 Jan 10;26(2):201-14. Epub 2007 Nov 20.

PMID:
18063235
18.

Development of an M2e-specific enzyme-linked immunosorbent assay for differentiating infected from vaccinated animals.

Lambrecht B, Steensels M, Van Borm S, Meulemans G, van den Berg T.

Avian Dis. 2007 Mar;51(1 Suppl):221-6.

PMID:
17494557
19.

Cloning, expression and purification of the influenza A (H9N2) virus M2e antigen and truncated Mycobacterium tuberculosis HSP70 as a fusion protein in Pichia pastoris.

Ebrahimi SM, Tebianian M, Toghyani H, Memarnejadian A, Attaran HR.

Protein Expr Purif. 2010 Mar;70(1):7-12. doi: 10.1016/j.pep.2009.11.001. Epub 2009 Nov 6.

PMID:
19897044
20.

Multimeric recombinant M2e protein-based ELISA: a significant improvement in differentiating avian influenza infected chickens from vaccinated ones.

Hadifar F, Ignjatovic J, Tarigan S, Indriani R, Ebrahimie E, Hasan NH, McWhorter A, Putland S, Ownagh A, Hemmatzadeh F.

PLoS One. 2014 Oct 16;9(10):e108420. doi: 10.1371/journal.pone.0108420. eCollection 2014.

Supplemental Content

Support Center